文献速递消化道肿瘤与早癌消化内镜

韩国国家癌症筛查项目在降低胃癌死亡率方面的有效性

Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.
PubMed 文献 · Gastroenterology · 2017-01-29

该研究采用巢式病例对照设计,评估韩国国家癌症筛查项目中上消化道内镜与上消化道系列检查对胃癌死亡的影响。结果显示,曾接受筛查者胃癌死亡总体OR为0.79(95%CI 0.77-0.81);上消化道内镜OR为0.53(95%CI 0.51-0.56),上消化道系列检查OR为0.98(95%CI 0.95-1.01)。结论认为接受上消化道内镜者死于胃癌的可能性较低,而上消化道系列检查未发现关联。

要点

  • 曾接受筛查者胃癌死亡总体OR为0.79(95%CI 0.77-0.81)。
  • 上消化道内镜筛查者胃癌死亡OR为0.53(95%CI 0.51-0.56)。
  • 上消化道系列检查者胃癌死亡OR为0.98(95%CI 0.95-1.01),未发现关联。

核心结论

  • 在韩国国家癌症筛查项目内,接受上消化道内镜者死于胃癌的可能性较低;上消化道系列检查未发现关联。

研究设计与样本

  • 采用巢式病例对照研究,数据来自2002年以来韩国国家癌症筛查项目。
  • 无癌队列共16,584,283名40岁及以上韩国男女。
  • 病例组为2004年1月至2009年12月新诊断胃癌且于2012年12月前死亡者(n=54,418)。
  • 对照为对应病例死亡日期仍存活者(n=217,672),按进入队列年份、年龄、性别和社会经济状态匹配。
  • 采用条件logistic回归分析获得OR及95%CI。

主要发现

  • 与从未筛查者相比,曾接受筛查者胃癌死亡总体OR为0.79(95%CI 0.77-0.81)。
  • 按筛查方式,上消化道内镜的胃癌死亡OR为0.53(95%CI 0.51-0.56),上消化道系列检查为0.98(95%CI 0.95-1.01)。
  • 随每例受试者接受内镜筛查次数增加,胃癌死亡OR降低:1次为0.60(95%CI 0.57-0.63),2次为0.32(95%CI 0.28-0.37),3次及以上为0.19(95%CI 0.14-0.26)。

关键数值与推荐

  • 上消化道内镜筛查的胃癌死亡OR为0.53(95%CI 0.51-0.56)。
  • 上消化道系列检查的胃癌死亡OR为0.98(95%CI 0.95-1.01)。
  • 内镜筛查1次、2次、3次及以上的胃癌死亡OR分别为0.60(95%CI 0.57-0.63)、0.32(95%CI 0.28-0.37)、0.19(95%CI 0.14-0.26)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It is not clear whether screening for gastric cancer by upper endoscopy or upper gastrointestinal (UGI) series examinations (looking at the upper and middle sections of the gastrointestinal tract by imaging techniques) reduces mortality. Nevertheless, the Korean National Cancer Screening Program for gastric cancer was launched in 1999 to screen individuals 40 years and older for gastric cancer using these techniques. We evaluated the effectiveness of these techniques in gastric cancer detection and compared their effects on mortality in the Korean population. METHODS: We performed a nested case-control study using data from the Korean National Cancer Screening Program for gastric cancer since 2002. A total of 16,584,283 Korean men and women, aged 40 years and older, comprised the cancer-free cohort. Case subjects (n = 54,418) were defined as individuals newly diagnosed with gastric cancer from January 2004 through December 2009 and who died before December 2012. Cases were matched with controls (subjects who were alive on the date of death of the corresponding case subject, n = 217,672) for year of entry into the study cohort, age, sex, and socioeconomic status. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained via conditional logistic regression analysis. RESULTS: Compared with subjects who had never been screened, the overall OR for dying from gastric cancer among ever-screened subjects was 0.79 (95% CI, 0.77-0.81). According to screening modality, the ORs of death from gastric cancer were 0.53 (95% CI, 0.51-0.56) for upper endoscopy and 0.98 (95% CI, 0.95-1.01) for UGI series. As the number of endoscopic screening tests performed per subject increased, the ORs of death from gastric cancer decreased: 0.60 (95% CI, 0.57-0.63), 0.32 (95% CI, 0.28-0.37), and 0.19 (95% CI, 0.14-0.26) for once, twice, and 3 or more times, respectively. CONCLUSIONS: Within the Korean National Cancer Screening Program, patients who received an upper endoscopy were less likely to die from gastric cancer; no associations were found for UGI series.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology. 2017. PMID: 28147224. doi:10.1053/j.gastro.2017.01.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。